Wedbush Securities’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.28M | Buy |
12,351
+1,590
| +15% | +$180K | 0.04% | 378 |
|
|
2025
Q4 | $1.08M | Buy |
10,761
+964
| +10% | +$105K | 0.03% | 424 |
|
|
2025
Q3 | $1.21M | Buy |
9,797
+1,143
| +13% | +$142K | 0.04% | 374 |
|
|
2025
Q2 | $1.04M | Buy |
8,654
+1,163
| +16% | +$155K | 0.04% | 411 |
|
|
2025
Q1 | $1.1M | Sell |
7,491
-133
| -2% | -$20.3K | 0.04% | 366 |
|
|
2024
Q4 | $1.24M | Buy |
7,624
+94
| +1% | +$15.4K | 0.04% | 314 |
|
|
2024
Q3 | $1.23M | Buy |
7,530
+539
| +8% | +$79.9K | 0.05% | 317 |
|
|
2024
Q2 | $954K | Buy |
6,991
+291
| +4% | +$40.4K | 0.03% | 395 |
|
|
2024
Q1 | $1.03M | Buy |
6,700
+353
| +6% | +$52.7K | 0.04% | 375 |
|
|
2023
Q4 | $905K | Sell |
6,347
-11
| -0.2% | -$1.47K | 0.04% | 352 |
|
|
2023
Q3 | $833K | Buy |
6,358
+687
| +12% | +$104K | 0.04% | 355 |
|
|
2023
Q2 | $902K | Sell |
5,671
-703
| -11% | -$113K | 0.04% | 343 |
|
|
2023
Q1 | $1.01M | Buy |
6,374
+234
| +4% | +$35.1K | 0.05% | 314 |
|
|
2022
Q4 | $862K | Buy |
6,140
+52
| +0.9% | +$7.38K | 0.05% | 342 |
|
|
2022
Q3 | $782K | Buy |
6,088
+238
| +4% | +$34.3K | 0.04% | 349 |
|
|
2022
Q2 | $825K | Sell |
5,850
-135
| -2% | -$19.3K | 0.04% | 341 |
|
|
2022
Q1 | $832K | Buy |
5,985
+44
| +0.7% | +$6.74K | 0.04% | 394 |
|
|
2021
Q4 | $1.04M | Buy |
5,941
+309
| +5% | +$51.5K | 0.04% | 366 |
|
|
2021
Q3 | $933K | Buy |
5,632
+464
| +9% | +$79.9K | 0.04% | 377 |
|
|
2021
Q2 | $930K | Sell |
5,168
-2,300
| -31% | -$420K | 0.04% | 388 |
|
|
2021
Q1 | $1.44M | Buy |
7,468
+489
| +7% | +$94.1K | 0.08% | 233 |
|
|
2020
Q4 | $1.41M | Buy |
6,979
+2,153
| +45% | +$446K | 0.12% | 176 |
|
|
2020
Q3 | $1.01M | Sell |
4,826
-390
| -7% | -$86.8K | 0.1% | 223 |
|
|
2020
Q2 | $1.14M | Sell |
5,216
-528
| -9% | -$105K | 0.11% | 195 |
|
|
2020
Q1 | $995K | Buy |
5,744
+563
| +11% | +$93K | 0.12% | 179 |
|
|
2019
Q4 | $795K | Buy |
5,181
+65
| +1% | +$9.71K | 0.07% | 317 |
|
|
2019
Q3 | $777K | Sell |
5,116
-6
| -0.1% | -$949 | 0.08% | 293 |
|
|
2019
Q2 | $784K | Buy |
5,122
+32
| +0.6% | +$4.89K | 0.08% | 291 |
|
|
2019
Q1 | $817K | Sell |
5,090
-109
| -2% | -$16.9K | 0.09% | 262 |
|
|
2018
Q4 | $801K | Buy |
5,199
+93
| +2% | +$14.5K | 0.1% | 235 |
|
|
2018
Q3 | $768K | Sell |
5,106
-35
| -0.7% | -$4.97K | 0.09% | 254 |
|
|
2018
Q2 | $695K | Buy |
5,141
+453
| +10% | +$55.9K | 0.09% | 280 |
|
|
2018
Q1 | $624K | Sell |
4,688
-1,436
| -23% | -$193K | 0.08% | 296 |
|
|
2017
Q4 | $911K | Buy |
6,124
+65
| +1% | +$8.84K | 0.11% | 222 |
|
|
2017
Q3 | $799K | Sell |
6,059
-495
| -8% | -$66.5K | 0.1% | 231 |
|
|
2017
Q2 | $873K | Buy |
6,554
+1,108
| +20% | +$150K | 0.11% | 226 |
|
|
2017
Q1 | $734K | Sell |
5,446
-1,275
| -19% | -$165K | 0.1% | 246 |
|
|
2016
Q4 | $807K | Buy |
6,721
+1,040
| +18% | +$123K | 0.12% | 212 |
|
|
2016
Q3 | $711K | Buy |
5,681
+1,182
| +26% | +$155K | 0.11% | 219 |
|
|
2016
Q2 | $623K | Buy |
4,499
+518
| +13% | +$67.2K | 0.1% | 222 |
|
|
2016
Q1 | $502K | Buy |
3,981
+192
| +5% | +$24.4K | 0.09% | 260 |
|
|
2015
Q4 | $481K | Buy |
3,789
+83
| +2% | +$10.3K | 0.09% | 252 |
|
|
2015
Q3 | $428K | Sell |
3,706
-1,764
| -32% | -$198K | 0.09% | 267 |
|
|
2015
Q2 | $569K | Sell |
5,470
-61
| -1% | -$6.58K | 0.11% | 234 |
|
|
2015
Q1 | $611K | Buy |
5,531
+168
| +3% | +$18.2K | 0.1% | 222 |
|
|
2014
Q4 | $559K | Sell |
5,363
-260
| -5% | -$26K | 0.09% | 240 |
|
|
2014
Q3 | $540K | Sell |
5,623
-414
| -7% | -$37.4K | 0.08% | 247 |
|
|
2014
Q2 | $552K | Buy |
6,037
+774
| +15% | +$69.3K | 0.09% | 243 |
|
|
2014
Q1 | $463K | Buy |
5,263
+160
| +3% | +$14K | 0.08% | 253 |
|
|
2013
Q4 | $473K | Buy |
5,103
+120
| +2% | +$10.8K | 0.11% | 218 |
|
|
2013
Q3 | $407K | Buy |
4,983
+43
| +0.9% | +$3.63K | 0.11% | 223 |
|
|
2013
Q2 | $411K | Buy |
+4,940
| New | +$425K | 0.11% | 224 |
|
Other funds holding CLX
VCM
VPM
DAM
Wedbush Securities's CLX Position: Q1 2026 in Review
Wedbush Securities increased its Clorox (CLX) stake by 15% in Q1 2026, buying an estimated $180K and bringing the position to 12,351 shares worth $1.28M. The position accounts for 0.04% of the portfolio, ranked #378.
Wedbush Securities first reported a position in CLX in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.44M in Q1 2021. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.
- Wedbush Securities held 12,351 shares of Clorox worth $1.28M as of Q1 2026.
- Wedbush Securities bought 1,590 Clorox shares in Q1 2026, an estimated $180K.
- Clorox made up 0.04% of Wedbush Securities's portfolio in Q1 2026, its #378 holding.
- Wedbush Securities first reported a position in Clorox in Q2 2013 and has held it in 52 quarters since.
- Wedbush Securities's Clorox position peaked at $1.44M in Q1 2021.
- 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.
Based on Wedbush Securities's 13F filing for Q1 2026, filed 21 Apr 2026.